期刊
ACS MEDICINAL CHEMISTRY LETTERS
卷 10, 期 1, 页码 62-66出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.8b00415
关键词
Soluble epoxide hydrolase (sEH); 5-Lipoxygenase activating protein (FLAP); Arachidonic acid cascade; Diflapolin; Inflammation
资金
- German Research Council [SFB1278 Polytarget, GA 2101/2-1]
- University of Innsbruck (Doktoratsstipendium der Nachwuchsforderung)
- Austrian Science Fund (FWF) [T942-B30]
A series of derivatives of the potent dual soluble epoxide hydrolase (sEH)/5-lipoxygenase-activating protein (FLAP) inhibitor diflapolin was designed, synthesized, and characterized by H-1 NMR, C-13 NMR, and elemental analysis. These novel compounds were biologically evaluated for their inhibitory activity against sEH and FLAP. Molecular modeling tools were applied to analyze structure-activity relationships (SAR) on both targets. Results show that even small modifications on the lead compound diflapolin markedly influence the inhibitory potential, especially on FLAP, suggesting very narrow SAR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据